Cell Therapeutics (CTIC) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Therapeutics (CTIC)

CTIC 9.090

0.0%

Jun 26 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: keokalani'nui who wrote (796)	2/10/2006 2:06:35 PM
From: Icebrg	Read Replies (1) of 946

Whoaa, not so fast. It is not the difference between men and women, that is the rationale for running the new trial. It is the difference seen between women treated with Xyotax and woman treated with conventional chemotherapy. And this difference was especially pronounced with premenopausal women. The sample size was small though, but the p-value "good". Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next